Clinical Trial Update: Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating clofarabine in combination with low-dose cytarabine for myelodysplastic syndromes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Clofarabine (Clolar) (clofarabine)
• Cytarabine (Cytosar) (cytarabine)

Snippet

Sponsor: Fondazione Italiana Sindromi Mielodisplastiche-ETS | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: WITHDRAWN